Nominations Invited For Inaugural $250,000 Kabiller Prize In Nanoscience And Nanomedicine
International prize recognizes advances in nanotechnology for medicine and biology
- International Institute for Nanotechnology establishes major prize for visionary researchers
- Inaugural $250,000 prize to be awarded in September 2015 and every other year thereafter
- A $10,000 prize recognizing young researchers also is established
- Nominations being accepted through June 22, 2015
EVANSTON, Ill. --- Northwestern University’s International Institute for Nanotechnology (IIN) has announced the establishment of the $250,000 Kabiller Prize in Nanoscience and Nanomedicine and the $10,000 Kabiller Young Investigator Award in Nanoscience and Nanomedicine.
The inaugural international prizes will be awarded in September 2015 and every other year thereafter. The deadline for nominations for the Kabiller Prize and Young Investigator Award is June 22, 2015. Details are available on the IIN website.
The Kabiller Prize will recognize individuals who have made the most significant contributions to the field of nanotechnology and its application to medicine and biology. The Kabiller Young Investigator Award will recognize young researchers who have made a recent groundbreaking discovery with the potential to make a lasting impact in the same arena.
Nanoscience is the study of the chemical and physical consequences of miniaturization, and nanotechnology, often aimed at tackling important societal problems, is the development of materials and devices based upon such consequences. There is increasing optimism that nanotechnology applied to medicine and biology will bring life-changing advances in the diagnosis, treatment and prevention of disease.
The IIN at Northwestern is a global leader in the field of nanotechnology in general and nanomedicine in particular. Through a generous donation from Northwestern trustee David G. Kabiller, the IIN is establishing the biennial Kabiller Prize and the Kabiller Young Investigator Award.
“The IIN at Northwestern University is a hub of excellence in the field of nanotechnology,” said Kabiller, chair of the IIN executive council and a graduate of Northwestern’s Weinberg College of Arts and Sciences and Kellogg School of Management. “As such, it is the ideal organization from which to launch an award to recognize outstanding achievements that have the potential to substantially benefit society.”
Kabiller is co-founder of AQR Capital Management, a global investment management firm in Greenwich, Connecticut, distinguished for its emphasis on ideas and research. He is an entrepreneur dedicated to supporting innovative research and technology and has been an active supporter of the cross-disciplinary field of nanotechnology.
“Nanotechnology is one of the key areas of distinction at Northwestern University,” President Morton Schapiro said.”We are very grateful to David for his support and look forward to ensuring that these prestigious awards recognize significant achievements and inspire interdisciplinary inventors for years to come.”
The recipients of the inaugural Kabiller Prize and Kabiller Young Investigator Award will be honored at an awards banquet Sept. 29 in Chicago and recognized at the 2015 IIN Symposium, which will include talks from prestigious speakers such as 2014 Nobel Prize in Chemistry winner William E. Moerner.
Nominations for the Kabiller Prize and the Kabiller Young Investigator Award will be reviewed and winners chosen by a selection committee made up of a group of world-renowned experts in nanotechnology and its application to the field of medicine and biology.
The deadline for nominations for the Kabiller Prize and Kabiller Young Investigator Award is June 22, 2015. Winners will be announced in August 2015. Additional nomination details can be found on the IIN website. Current Northwestern-affiliated researchers are not eligible for nomination until 2018 for the 2019 prizes.
About Northwestern’s International Institute for Nanotechnology
The IIN houses a National Institutes of Health Center for Cancer Nanotechnology Excellence, a U.S. Department of Defense In vivo Nanoplatform Therapeutics Program, the Ronald and JoAnne Willens Center for Nano Oncology, a Nanomedicine Institute in partnership with the Nanyang Technological Institute in Singapore, and a sister Institute for Chemical Biology and Nanomedicine at Hunan University in China.
In total, the IIN represents and unites more than $800 million in nanotechnology infrastructure, research and education. These efforts, plus those of many other groups, have helped transition nanomedicine from a laboratory curiosity to life-changing technologies that are positively impacting the world.